"Foscarnet" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
| Descriptor ID |
D017245
|
| MeSH Number(s) |
D02.241.081.018.677.250 D02.705.429.875.500
|
| Concept/Terms |
Foscarnet Sodium- Foscarnet Sodium
- Sodium, Foscarnet
- Foscarnet Trisodium Salt
- Trisodium Salt, Foscarnet
- Foscarnet Sodium Hexahydrate
- Hexahydrate, Foscarnet Sodium
- Sodium Hexahydrate, Foscarnet
- Trisodium Phosphonoformate
- Phosphonoformate, Trisodium
|
Below are MeSH descriptors whose meaning is more general than "Foscarnet".
Below are MeSH descriptors whose meaning is more specific than "Foscarnet".
This graph shows the total number of publications written about "Foscarnet" by people in this website by year, and whether "Foscarnet" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Foscarnet" by people in Profiles.
-
Moss HB, Chavala S, Say E, Miller MB. Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma. J Clin Microbiol. 2012 May; 50(5):1796-9.
-
Laibson PR. Resistant herpes simplex keratitis. Clin Exp Ophthalmol. 2010 Apr; 38(3):227-8.
-
Kim SJ, Equi R, Belair ML, Fine HF, Dunn JP. Long-term preservation of vision in progressive outer retinal necrosis treated with combination antiviral drugs and highly active antiretroviral therapy. Ocul Immunol Inflamm. 2007 Nov-Dec; 15(6):425-7.
-
Jabs DA, Enger C, Dunn JP, Forman M, Hubbard L. Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group. Am J Ophthalmol. 1998 Oct; 126(4):543-9.
-
Jabs DA, Enger C, Forman M, Dunn JP. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group. Antimicrob Agents Chemother. 1998 Sep; 42(9):2240-4.
-
Jabs DA, Dunn JP, Enger C, Forman M, Bressler N, Charache P. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group. Arch Ophthalmol. 1996 Jul; 114(7):809-14.
-
Dunn JP, MacCumber MW, Forman MS, Charache P, Apuzzo L, Jabs DA. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol. 1995 May; 119(5):587-96.
-
Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM, Flomenberg N, Carrigan DR. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis. 1993 Mar; 167(3):735-9.